Morgan Stanley’s Escalon Medical Corp ESMC Stock Holding History

Morgan Stanley’s Portfolio ESMC Stock Details ESMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500	Closed	–	–	6668
2016 Q3	$0	Hold	500	–	–	﹤0.01%	6639
2016 Q2	$0	Sell	500 -12	-2%	-$9	﹤0.01%	6841
2016 Q1	$0	Sell	512 -501	-49%	-$464	﹤0.01%	6882
2015 Q4	$2K	Buy	1,013 +13	+1%	+$14	﹤0.01%	6537
2015 Q3	$2K	Sell	1,000 -14	-1%	-$18	﹤0.01%	6507
2015 Q2	$2K	Buy	1,014 +1	+0.1%	+$1	﹤0.01%	6534
2015 Q1	$2K	Hold	1,013	–	–	﹤0.01%	6454
2014 Q4	$2K	Hold	1,013	–	–	﹤0.01%	6457
2014 Q3	$2K	Hold	1,013	–	–	﹤0.01%	6461
2014 Q2	$2K	Hold	1,013	–	–	﹤0.01%	6408
2014 Q1	$2K	Buy	1,013 +13	+1%	+$23	﹤0.01%	6367
2013 Q4	$2K	Buy	+1,000	New	+$1.62K	﹤0.01%	6271

Other funds holding ESMC

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Morgan Stanley's ESMC Position: Q4 2016 in Review

Morgan Stanley sold out of Escalon Medical Corp (ESMC) in Q4 2016, closing a stake of 500 shares.

Morgan Stanley first reported a position in ESMC in Q4 2013 and held it in 12 quarters. The position peaked at $2K in Q4 2015. 3 funds tracked by Wall St. Rank hold ESMC as of Q4 2016.

Morgan Stanley reported no remaining Escalon Medical Corp position as of Q4 2016 after selling out during the quarter.
Morgan Stanley sold 500 Escalon Medical Corp shares in Q4 2016.
Morgan Stanley first reported a position in Escalon Medical Corp in Q4 2013 and held it in 12 quarters.
Morgan Stanley's Escalon Medical Corp position peaked at $2K in Q4 2015.
3 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q4 2016.

Based on Morgan Stanley's 13F filing for Q4 2016, filed 13 Feb 2017.